
Therapeutic Vaccines Market
Therapeutic Vaccines Market - Global Industry Assessment & Forecast
Segments Covered
By Product Addiction Vaccines, Autoimmune Disease Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines
By Technology Autologous Vaccines, Allogeneic Vaccines
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2023 |
![]() |
2024 - 2032 |
![]() |
2018 - 2022 |
![]() |
USD 31 Billion |
![]() |
USD 140 Billion |
![]() |
18.2% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Therapeutic Vaccines Market - Segment Analysis
- Overview
- Global Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
Global Therapeutic Vaccines Market - by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
Global Therapeutic Vaccines Market - by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
Global Therapeutic Vaccines Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Therapeutic Vaccines Market - Segment Analysis
- Overview
- North America Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
North America Therapeutic Vaccines Market, by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
North America Therapeutic Vaccines Market, by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
North America Therapeutic Vaccines Market, by Country
- U.S.
- U.S. Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- U.S. Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- U.S. Therapeutic Vaccines Market, By Product
- Canada
- Canada Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Canada Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Canada Therapeutic Vaccines Market, By Product
- Mexico
- Mexico Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Mexico Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Mexico Therapeutic Vaccines Market, By Product
- U.S.
-
Europe Therapeutic Vaccines Market - Segment Analysis
- Overview
- Europe Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
Europe Therapeutic Vaccines Market, by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
Europe Therapeutic Vaccines Market, by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
Europe Therapeutic Vaccines Market, by Country
- Germany
- Germany Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Germany Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Germany Therapeutic Vaccines Market, By Product
- UK
- UK Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- UK Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- UK Market, By Product
- France
- France Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- France Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- France Therapeutic Vaccines Market, By Product
- Spain
- Spain Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Spain Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Spain Therapeutic Vaccines Market, By Product
- Italy
- Italy Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Italy Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Italy Therapeutic Vaccines Market, By Product
- BENELUX
- BENELUX Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- BENELUX Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- BENELUX Therapeutic Vaccines Market, By Product
- Rest of Europe
- Rest Of Europe Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Rest Of Europe Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Rest Of Europe Therapeutic Vaccines Market, By Product
- Germany
-
Asia Pacific Therapeutic Vaccines Market - Segment Analysis
- Overview
- Asia Pacific Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
Asia Pacific Therapeutic Vaccines Market, by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
Asia Pacific Therapeutic Vaccines Market, by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
Asia Pacific Therapeutic Vaccines Market, by Country
- China
- China Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- China Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- China Therapeutic Vaccines Market, By Product
- Japan
- Japan Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Japan Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Japan Therapeutic Vaccines Market, By Product
- India
- India Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- India Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- India Therapeutic Vaccines Market, By Product
- South Korea
- South Korea Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- South Korea Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- South Korea Therapeutic Vaccines Market, By Product
- South East Asia
- South East Asia Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- South East Asia Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- South East Asia Therapeutic Vaccines Market, By Product
- Rest of Asia Pacific
- Rest of Asia Pacific Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Rest of Asia Pacific Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Rest of Asia Pacific Therapeutic Vaccines Market, By Product
- China
-
Latin America Therapeutic Vaccines Market - Segment Analysis
- Overview
- Latin America Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
Latin America Therapeutic Vaccines Market, by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
Latin America Therapeutic Vaccines Market, by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
Latin America Therapeutic Vaccines Market, by Country
- Brazil
- Brazil Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Brazil Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Brazil Therapeutic Vaccines Market, By Product
- Argentina
- Argentina Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Argentina Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Argentina Therapeutic Vaccines Market, By Product
- Rest of Latin America
- Rest of Latin America Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Rest of Latin America Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Rest of Latin America Therapeutic Vaccines Market, By Product
- Brazil
-
Middle East & Africa Therapeutic Vaccines Market - Segment Analysis
- Overview
- Middle East & Africa Therapeutic Vaccines Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Therapeutic Vaccines Market, by Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
-
Middle East & Africa Therapeutic Vaccines Market, by Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
-
Middle East & Africa Therapeutic Vaccines Market, by Country
- GCC Countries
- GCC Countries Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- GCC Countries Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- GCC Countries Therapeutic Vaccines Market, By Product
- South Africa
- South Africa Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- South Africa Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- South Africa Therapeutic Vaccines Market, By Product
- Rest of Middle East & Africa
- Rest of Middle East & Africa Therapeutic Vaccines Market, By Product
- By Addiction Vaccines
- By Autoimmune Disease Vaccines
- By Neurological Disease Vaccines
- By Infectious Disease Vaccines
- Rest of Middle East & Africa Therapeutic Vaccines Market, By Technology
- By Autologous Vaccines
- By Allogeneic Vaccines
- Rest of Middle East & Africa Therapeutic Vaccines Market, By Product
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Agenus Inc. (U.S.)
- Argos Therapeutics Inc. (U.S.)
- Bavarian Nordic A/S (Denmark)
- Cel-Sci Corp. (U.S.)
- CSL Ltd. (Australia)
- Emergent Biosolutions Inc. (U.S.)
- GSK PLC (UK)
- Merck & Co. Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Sanofi S.A. (France)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Therapeutic Vaccines in terms of revenue?
-
The global Therapeutic Vaccines valued at USD 31 Billion in 2023 and is expected to reach USD 140 Billion in 2032 growing at a CAGR of 18.2%.
Which are the prominent players in the market?
-
The prominent players in the market are Agenus Inc. (U.S.), Argos Therapeutics Inc. (U.S.), Bavarian Nordic A/S (Denmark), Cel-Sci Corp. (U.S.), CSL Ltd. (Australia), Emergent Biosolutions Inc. (U.S.), GSK PLC (UK), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Sanofi S.A. (France).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 18.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Therapeutic Vaccines include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Therapeutic Vaccines in 2023.